$1.43
0.021.42%
Last update: Nov 4, 12:11 PM

The average analyst price target for Equillium is $8.71, 509.1% above the current price. Of 7 analysts, 6 rate it Buy and 1 Hold. Targets range from $5 to $20. The latest change came on Oct 12, 2026, when Leerink Partners assumed coverage of Equillium with an Outperform rating and a $6 price target.
Price Target Range — 8 Quarters
Analyst Consensus — 7 Analysts
Rating Trend — Last 9 Months